Western Norway Regional Health Authority   Report issue

Government Phase 2 Phase 4
Founded: Stavanger Norway (2002)

Organization Overview

First Clinical Trial
2008
NCT00751933
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Helse Vest

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Breast Neoplasms (Phase 2)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Communicable Diseases (Phase 4)

Compulsive Personality Disorder (Phase 4)

Infarction (Phase 4)

Infections (Phase 4)

Mental Disorders (Phase 4)

Myocardial Infarction (Phase 4)

Obsessive-Compulsive Disorder (Phase 4)

Opportunistic Infections (Phase 4)

Pneumonia (Phase 4)

Pneumonia, Pneumocystis (Phase 4)

Psychotic Disorders (Phase 4)

Schizophrenia (Phase 4)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 23